NL-OMON41282已完成不适用
Early mitral valve repair versus watchful waiting in asymptomatic patients with severe organic mitral regurgitation; a multicenter, randomised trial. - Dutch AMR
niversitair Medisch Centrum Utrecht0 个研究点目标入组 250 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •- 18-75 years.
- •- Asymptomatic patients. *Asymptomatic* is defined as absence of subjective limitations of exercise capacity or complaints expressed by the patient and confirmed by the treating cardiologist.
- •- Severe organic mitral valve regurgitation. *Severe organic mitral valve regurgitation* is defined as non-ischemic mitral valve regurgitation with an organic cause (intrinsic valve lesion) as determined by echocardiographic core-lab reading based on the criteria for definition of severe mitral regurgitation as issued by the ESC guidelines. For practical reasons, referring cardiologists can use a ESC guidelines based index that was validated in our core-lab (Jansen et al, Practical echocardiographic semi-quantitative scoring system to determine severity of mitral regurgitation. Abstract presentation at ESC EUROECHO Congress 2011 and annual spring congress 2012 Netherlands Society of Cardiology).
- •- Preserved left ventricular function, *Preserved left ventricular function* is defined as left ventricular ejection fraction >60% and left ventricular end-systolic dimension <45 mm.
- •- The likelihood of MV repair should be more than 90% determined by the local heart team with a cardiologist and cardiothoracic surgeon.
排除标准
- •- Pulmonary hypertension (>50 mmHg at rest).
- •- Atrial fibrillation, either on 12-lead ECG or holter-monitoring.
- •- Physical inability as determined by the heart team to undergo surgery.
- •- Other life-threatening morbidity.
- •- Higher expected surgical risks in advanve, according to the dedicated heart team.
- •- Patients with moderate to severe kidney disease (estimated glomerular filtration rate (eGFR) less than 30 mL/min).
- •- Flail leaflet together with a left ventricular end systolic diameter (LVESD) >=40 mm
研究者
相似试验
终止
不适用
The Dutch Asymptomatic Mitral Regurgitation TrialHeart; Disease, Mitral(Valve)Diseases of Mitral ValveMitral Valve InsufficiencyNCT01708265UMC Utrecht12
已完成
不适用
The effects of interventional mitral valverepair with the MitraClip system on theresults of pulmonary function testingDRKS00022435Helios Klinikum Pirna100
已完成
不适用
Postoperative prognosis of mitral valve repair due to the difference in mitral annular measurement between sizer and transesophageal echocardiographymitral valve repair for mitral regurgitationJPRN-UMIN000025515ational Cerebral and Cardiovascular Center140
已完成
不适用
Postoperative prognosis of mitral valve repair due to the morphological change of mitral valve by using transesophageal echocardiographymitral valve repair for mitral regurgitationJPRN-UMIN000025794ational Cerebral and Cardiovascular Center50
尚未招募
2 期
Study of using patients own tissues to construct mitral valve compared to mechanical valve replacementCTRI/2021/04/032759Sri Jayadeva institute of Cardiovascular Sciences and research
